Best Fit Health/Biotechnology Funds ETFs
U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 14 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.
| Best Fit Scorecard | |
|---|---|
| Costs | Typical |
| Tracking Error | Typical |
| Bid/Ask Ratio | Good |
| Holdings Diversity | Typical |
Fund Description
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.
Fund Snapshot Updated 05.21.2013
| Previous Close | — | Expense Ratio | 0.60% |
| YTD Return | 29.9% | Avg. 30-Day Volume | 54,680 |
| 1-Year Return | 37.1% | Market Cap | Loading... |
| Bid | $59.62 | Shares Outstanding | 5,850,000 |
| Ask | $59.67 | Dividends | $0.00 |
| Top 10 Holdings | |
|---|---|
| Illumina Inc (ILMN) | 6.19% |
| Regeneron Pharmaceuticals (REGN) | 5.85% |
| Myriad Genetics Inc (MYGN) | 5.52% |
| Immunogen Inc (IMGN) | 5.49% |
| Biogen Idec Inc (BIIB) | 5.45% |
| United Therapeutics Corp Del (UTHR) | 5.44% |
| Alexion Pharmaceuticals Inc (ALXN) | 5.31% |
| Intermune Inc (ITMN) | 5.20% |
| Gilead Sciences Inc (GILD) | 5.08% |
| Incyte Corp (INCY) | 4.91% |
| % of Total Holdings | 54.40% |
